This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2010 Mar;9(3):229-36.

doi: 10.1586/erv.10.6.

Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe

Ralf R Reinert, Peter Paradiso, Bernard Fritzell

PMID: 20218848
DOI: 10.1586/erv.10.6

Review

Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe

Ralf R Reinert et al. Expert Rev Vaccines. 2010 Mar.

. 2010 Mar;9(3):229-36.

doi: 10.1586/erv.10.6.

Authors

Ralf R Reinert, Peter Paradiso, Bernard Fritzell

PMID: 20218848
DOI: 10.1586/erv.10.6

No abstract available

PubMed Disclaimer

Similar articles

Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
Rose M, Zielen S. Rose M, et al. Expert Rev Vaccines. 2009 Oct;8(10):1351-64. doi: 10.1586/erv.09.78. Expert Rev Vaccines. 2009. PMID: 19803758 Review.
7-valent pneumococcal conjugate vaccine: new preparation. Prevents rare invasive infections in infants.
[No authors listed] [No authors listed] Prescrire Int. 2002 Feb;11(57):7-10. Prescrire Int. 2002. PMID: 11985376
Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2010 Mar 12;59(9):258-61. MMWR Morb Mortal Wkly Rep. 2010. PMID: 20224542
Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants.
[No authors listed] [No authors listed] Prescrire Int. 2006 Dec;15(86):227-33. Prescrire Int. 2006. PMID: 17167934
Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006).
Oosterhuis-Kafeja F, Beutels P, Van Damme P. Oosterhuis-Kafeja F, et al. Vaccine. 2007 Mar 8;25(12):2194-212. doi: 10.1016/j.vaccine.2006.11.032. Epub 2006 Dec 4. Vaccine. 2007. PMID: 17267077 Review.

See all similar articles

Cited by

Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60-85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study.
Fierro CA, Sarnecki M, Doua J, Spiessens B, Go O, Davies TA, van den Dobbelsteen G, Poolman J, Abbanat D, Haazen W. Fierro CA, et al. Open Forum Infect Dis. 2023 Aug 11;10(8):ofad417. doi: 10.1093/ofid/ofad417. eCollection 2023 Aug. Open Forum Infect Dis. 2023. PMID: 37608916 Free PMC article.
The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.
Cooper D, Yu X, Sidhu M, Nahm MH, Fernsten P, Jansen KU. Cooper D, et al. Vaccine. 2011 Sep 22;29(41):7207-11. doi: 10.1016/j.vaccine.2011.06.056. Epub 2011 Jul 18. Vaccine. 2011. PMID: 21689707 Free PMC article.
The stubborn persistence of adult pneumococcal pneumonia as a public health problem.
Hollingsworth R, Isturiz R. Hollingsworth R, et al. Hum Vaccin Immunother. 2014;10(5):1319-21. doi: 10.4161/hv.27986. Epub 2014 Feb 19. Hum Vaccin Immunother. 2014. PMID: 24553362 Free PMC article. No abstract available.
Capsule Prolongs Survival of Streptococcus pneumoniae during Starvation.
Hamaguchi S, Zafar MA, Cammer M, Weiser JN. Hamaguchi S, et al. Infect Immun. 2018 Feb 20;86(3):e00802-17. doi: 10.1128/IAI.00802-17. Print 2018 Mar. Infect Immun. 2018. PMID: 29311231 Free PMC article.
Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.
Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L. Weil-Olivier C, et al. BMC Infect Dis. 2012 Sep 7;12:207. doi: 10.1186/1471-2334-12-207. BMC Infect Dis. 2012. PMID: 22954038 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information